T Cells and TNF: The Impact of TNF Blockade on Effector T Cell Populations in Rheumatoid Arthritis and Other Conditions Treated With Anti-TNFalpha Agents
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary)
- Indications Ankylosing spondylitis; Psoriatic arthritis; Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 23 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Mar 2012 Planned end date (26 Nov 2012) as reported by European Clinical Trials Database.